Glucagon-like peptide-1 receptor agonist was not associated with an increased rate of pancreatitis in patients with T2D or obesity.

Supplemental multicancer early detection testing was linked to increases in stage I, II, and III and decreases in stage IV diagnoses.

Eligible patients will pay around $245 to $350 per month for Zepbound, Mounjaro, Ozempic, and Wegovy. HealthDay News — Two major drugmakers will slash the price of popular weight loss medications for ...

Among 8 obesity indices, body fat percentage showed the best discriminatory ability for predicting osteoarthritis and relative fat mass was most strongly associated with risk. Anthropometric indices ...

Compared with DPP4i, use of semaglutide, tirzepatide, and liraglutide were associated with lower incidence of alcohol use disorder among patients with type 2 diabetes. Tirzepatide, semaglutide, and ...

Gay and bisexual men vs heterosexual men have significantly higher odds of disorders of gut-brain interaction (DGBI), including irritable bowel syndrome (IBS), chronic constipation (CC), and ...

High frequency low-dose aspirin use was associated with lower risk for myocardial infarction and ischemic stroke than low-frequency use. HealthDay News — For adults with type 2 diabetes, low-dose ...

Mortality associated with chronic liver disease (CLD) and metabolic syndrome (MetS) increased substantially from 1999 to 2023 ...

Vonoprazan significantly improves nocturnal gastroesophageal reflux symptoms among patients with nonerosive reflux disease, providing rapid relief after the first dose.